Drug Liability in the News: FDA Removes Darvon and Darvocet | Andalman & Flynn Law Firm
We offer appointments by phone, video, or in-person.
Andalman and Flynn logo

Drug Liability in the News: FDA Removes Darvon and Darvocet from the Market

Nov 21, 2010 | Uncategorized

The U.S. Food and Drug Administration made national news over the weekend announcing they will pull the popular painkillers Darvon and Darvocet from pharmacy shelves.

Recent research revealed evidence that use of these painkillers may lead to serious and potentially fatal heart problems.

The active ingredient, propoxyphene, appears to be the culprit.  New research has led the FDA to take steps to ban this product. In 2009, the FDA was close to pulling the plug on Darvon and Darvocet with an FDA advisory panel voting to take action and blacklist the drugs, however, the FDA ultimately made the decision to keep the drugs on the market but continued studies on potential heart-health issues relating to these drugs.

If you are taking these drugs, the FDA recommends you consult your physician(s) immediately and that you do not stop taking the drug on your own. Darvon and Darvocet are manufactured by Xanodyne Pharmaceuticals.

Andalman & Flynn – We Can Help with Drug Liability Concerns!

While the FDA may license a drug, such licensing  does not provide immunity to pharmaceutical companies from being held liable for injuring a patient if a drug or medicine is deemed defective or harmful.

Determining liability may not be a clear-cut issue, with the pharmaceutical company, doctor, nurse, or pharmacist all playing a role in your treatment for a medical condition with medication.

At Andalman & Flynn, as experienced drug liability attorneys, we can help determine who is liable for injuries you have suffered from defective drugs and medicines.  Feel free to contact me, Mary Ellen Flynn, or any of our other attorneys if you have questions regarding drug liabilities.  We can be reached at 301-563-6685, or through our contact form to answer your questions and discuss your situation.

-Mary Ellen Flynn, Esq.
[email protected]